Zimmer Biomet Holdings 8-K Report: Key Debt & Stock Insights for Investors

Here are the key insights extracted from the provided financial report section for Zimmer Biomet Holdings, Inc.:

1. Entity Identification:

• Company Name: Zimmer Biomet Holdings, Inc.
• SEC CIK: 0001136869
• Address: 345 East Main Street, Warsaw, IN 46580
• Phone: (574) 373-3333

2. Filing Type:

• Form 8-K

3. Filing Date:

• February 25, 2025

4. Common Stock Information:

• Par Value: $0.01
• Trading Symbol: ZBH
• Exchange: NYSE

5. Debt Securities:

• 2.425% Notes due 2026: Identified as "zbh-M2.425NotesDue2026Member"
• 1.164% Notes due 2027: Identified as "zbh-M1.164NotesDue2027Member"
• 3.518% Notes due 2032: Identified as "zbh-M3.518NotesDue2032Member"

6. Context Information:

• All securities and stock are referenced under a specific context ID with a duration from February 25, 2025, to February 25, 2025, indicating that this is likely a snapshot or specific reporting date.

7. XBRL Reporting:

• The report is formatted using XBRL (eXtensible Business Reporting Language), which is used for the electronic communication of business and financial data.

Insights:

• The report indicates an update on the company’s debt obligations, suggesting monitoring of interest rates associated with the notes.
• The presence of multiple debt securities with different maturity dates suggests a structured approach to financing and managing cash flows.
• The common stock remains a core part of the company's capital structure, and the low par value indicates potential for high equity issuance without significant dilution.

Overall, this report reflects a standard corporate update regarding stock and debt securities, relevant for investors and analysts tracking Zimmer Biomet’s financial health and obligations.